文献速递神经肌肉病

多中心回顾性研究:MTMR相关CMT4B的临床与遗传特征

A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs).
PubMed 文献 · Ann Neurol · 2019-05-27

该多中心回顾性研究纳入50例CMT4B患者(含21例新报道),携带44种MTMR相关突变(21种为新突变)。CMT4B1较CMT4B2起病更早、表型更重(运动里程碑延迟、轮椅使用、呼吸受累更多,MRC评分更差),且疾病严重度随年龄增长进展更快;CMT4B2可见青光眼,而声带受累两型均常见。

要点

  • CMT4B1较CMT4B2起病更早、病情更重,呼吸受累及轮椅使用更常见。
  • CMT4B1疾病严重度与年龄显著相关且进展斜率更陡,提示预后更差。
  • 声带受累在CMT4B1和CMT4B2均常见,青光眼仅见于CMT4B2。

核心结论

  • CMT4B1的疾病严重程度显著高于CMT4B2,且CMT4B1的严重度随年龄增长进展更快,可据此估计预后。
  • MTMR2和MTMR13基因的大多数突变不影响疾病严重度与年龄的相关性,支持这些突变导致MTMR2/13蛋白完全功能丧失的假说。

研究设计与样本

  • 多中心回顾性研究,从18个中心收集CMT4B患者的临床与遗传数据,采用预设最小数据集(含9对肌肉的MRC评分和CMT神经病评分)。
  • 共纳入50例患者,其中21例为既往未报道者,携带44种突变(21种为新突变,6种为已知罕见变异的新疾病关联)。

主要发现

  • CMT4B1患者较CMT4B2起病更早,运动里程碑延迟、轮椅使用和呼吸受累更频繁,MRC评分和CMT检查评分中运动成分更差,尽管检查时年龄更轻。
  • 声带受累在CMT4B1和CMT4B2两个亚型中均常见,而青光眼仅见于CMT4B2。
  • 两个亚型的神经传导速度均相似地减慢。
  • 回归分析显示CMT4B1的疾病严重度与年龄显著相关,且斜率更陡,提示疾病进展更快。

临床怎么用

  • 对CMT4B1患者应更早关注呼吸功能、运动里程碑延迟及轮椅需求,并预期更快的疾病进展。
  • 对CMT4B2患者需筛查青光眼;两型均需评估声带受累。
  • 遗传学发现MTMR2/MTMR13突变多为功能丧失性,可辅助遗传咨询与预后判断。

局限性

  • 本研究为回顾性设计,可能存在选择偏倚与数据完整性限制。
  • 样本量较小(50例),且部分患者为既往未报道者,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Charcot-Marie-Tooth (CMT) disease 4B1 and 4B2 (CMT4B1/B2) are characterized by recessive inheritance, early onset, severe course, slowed nerve conduction, and myelin outfoldings. CMT4B3 shows a more heterogeneous phenotype. All are associated with myotubularin-related protein (MTMR) mutations. We conducted a multicenter, retrospective study to better characterize CMT4B. METHODS: We collected clinical and genetic data from CMT4B subjects in 18 centers using a predefined minimal data set including Medical Research Council (MRC) scores of nine muscle pairs and CMT Neuropathy Score. RESULTS: There were 50 patients, 21 of whom never reported before, carrying 44 mutations, of which 21 were novel and six representing novel disease associations of known rare variants. CMT4B1 patients had significantly more-severe disease than CMT4B2, with earlier onset, more-frequent motor milestones delay, wheelchair use, and respiratory involvement as well as worse MRC scores and motor CMT Examination Score components despite younger age at examination. Vocal cord involvement was common in both subtypes, whereas glaucoma occurred in CMT4B2 only. Nerve conduction velocities were similarly slowed in both subtypes. Regression analyses showed that disease severity is significantly associated with age in CMT4B1. Slopes are steeper for CMT4B1, indicating faster disease progression. Almost none of the mutations in the MTMR2 and MTMR13 genes, responsible for CMT4B1 and B2, respectively, influence the correlation between disease severity and age, in agreement with the hypothesis of a complete loss of function of MTMR2/13 proteins for such mutations. INTERPRETATION: This is the largest CMT4B series ever reported, demonstrating that CMT4B1 is significantly more severe than CMT4B2, and allowing an estimate of prognosis. ANN NEUROL 2019.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Pareyson D, Stojkovic T, Reilly MM, et al. A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs). Ann Neurol. 2019. PMID: 31070812. doi:10.1002/ana.25500

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。